- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/50 - Cyclic peptides containing at least one abnormal peptide link
Patent holdings for IPC class C07K 7/50
Total number of patents in this class: 309
10-year publication summary
|
15
|
14
|
28
|
20
|
14
|
17
|
26
|
11
|
18
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Protagonist Therapeutics, Inc. | 137 |
14 |
| Ohio State Innovation Foundation | 2166 |
10 |
| Centre National de La Recherche Scientifique | 10516 |
7 |
| The University of Tokyo | 4200 |
7 |
| Napp Pharmaceutical Group Limited | 22 |
6 |
| Peptidream Inc. | 80 |
6 |
| Bicyclerd Limited | 146 |
6 |
| Bristol-myers Squibb Company | 4867 |
5 |
| Chugai Seiyaku Kabushiki Kaisha | 1367 |
5 |
| University of Rochester | 1315 |
5 |
| Fog Pharmaceuticals, Inc. | 11 |
5 |
| Merck Sharp & Dohme Corp. | 2191 |
4 |
| Aileron Therapeutics, Inc. | 80 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2585 |
4 |
| Promis Neurosciences Inc. | 31 |
4 |
| The University of British Columbia | 1508 |
4 |
| Merck Sharp & Dohme LLC | 3760 |
4 |
| Apellis Pharmaceuticals, Inc. | 124 |
3 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
3 |
| Ferring B.V. | 705 |
3 |
| Other owners | 200 |